BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$487M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$393M |
| 3 |
Microsoft
MSFT
|
+$380M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$349M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$312M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Salesforce
CRM
|
+$765M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$368M |
| 4 |
Eli Lilly
LLY
|
+$255M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| 1 | Technology | 18.31% |
| 2 | Consumer Discretionary | 8.56% |
| 3 | Healthcare | 8.43% |
| 4 | Financials | 7.4% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2226
NGL Energy Partners
NGL
$740M
| $56K | ﹤0.01% |
14,364
+3,337
| +30% | +$13K |
|
2227
Unisys
UIS
$282M
| $55.2K | ﹤0.01% |
5,062
-16,800
| -77% | -$183K |
|
2228
PC Connection
CNXN
$1.6B
| $55.2K | ﹤0.01% |
1,190
-3,033
| -72% | -$141K |
|
2229
CorVel
CRVL
$4.39B
| $55K | ﹤0.01% |
2,328
-8,937
| -79% | -$211K |
|
2230
Dine Brands
DIN
$368M
| $54.9K | ﹤0.01% |
1,304
-5,494
| -81% | -$231K |
|
2231
Oceaneering
OII
$2.43B
| $54.7K | ﹤0.01% |
8,557
-243,257
| -97% | -$1.55M |
|
|
HTLF
2232
DELISTED
Heartland Financial USA, Inc.
HTLF
| $54.6K | ﹤0.01% |
1,634
-10,130
| -86% | -$339K |
|
2233
Lantheus
LNTH
$3.6B
| $54.5K | ﹤0.01% |
3,813
-11,646
| -75% | -$167K |
|
2234
Marcus & Millichap
MMI
$1.26B
| $54.5K | ﹤0.01% |
1,887
-7,834
| -81% | -$226K |
|
|
SPPI
2235
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $54.4K | ﹤0.01% |
16,095
-48,998
| -75% | -$166K |
|
2236
Southside Bancshares
SBSI
$916M
| $54.4K | ﹤0.01% |
1,962
-10,797
| -85% | -$299K |
|
2237
Chesapeake Utilities
CPK
$2.95B
| $54.3K | ﹤0.01% |
646
-4,300
| -87% | -$361K |
|
2238
BlueLinx
BXC
$617M
| $53.9K | ﹤0.01% |
6,287
+3,505
| +126% | +$30K |
|
2239
Flexsteel Industries
FLXS
$258M
| $53.8K | ﹤0.01% |
4,257
+1,949
| +84% | +$24.6K |
|
|
NTUS
2240
DELISTED
Natus Medical Inc
NTUS
| $53.7K | ﹤0.01% |
2,460
-11,402
| -82% | -$249K |
|
2241
Trupanion
TRUP
$1.87B
| $53.7K | ﹤0.01% |
1,257
-7,666
| -86% | -$327K |
|
2242
Inogen
INGN
$231M
| $53.6K | ﹤0.01% |
1,508
-6,216
| -80% | -$221K |
|
2243
Axcelis
ACLS
$2.69B
| $53.1K | ﹤0.01% |
1,905
-10,999
| -85% | -$306K |
|
2244
Novo Nordisk
NVO
$244B
| $52.8K | ﹤0.01% |
1,614
-17,186
| -91% | -$563K |
|
2245
Assembly Biosciences
ASMB
$168M
| $52.8K | ﹤0.01% |
189
-529
| -74% | -$148K |
|
2246
Veeco
VECO
$1.52B
| $52.7K | ﹤0.01% |
3,910
-195,678
| -98% | -$2.64M |
|
|
MNR
2247
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $52.7K | ﹤0.01% |
3,640
-37,186
| -91% | -$539K |
|
2248
Ambac
AMBC
$413M
| $52.5K | ﹤0.01% |
3,669
-15,150
| -81% | -$217K |
|
2249
Nelnet
NNI
$4.46B
| $52.5K | ﹤0.01% |
1,100
-4,890
| -82% | -$233K |
|
|
CEO
2250
DELISTED
CNOOC Limited
CEO
| $52.4K | ﹤0.01% |
464
-11,632
| -96% | -$1.31M |
|